Titre:
  • Results of the Belgian expanded acces program of eribulin (E) in the treatment of metastastic breast cancer (MBC) closely mirrors those of the pivotal phase III trial
Auteur:Polastro, Laura; Aftimos, Philippe; Ameye, L.; Vakili, Jalal; Paesmans, Marianne; Van Den Eerenbeemt, Joanne; Buttice, A; Gombos, Andrea; de Valeriola, Dominique; Piccart-Gebhart, Martine; Awada, Ahmad
Informations sur la publication:(2014), American Society of Clinical Oncology
Statut de publication:Publié, 2014
Sujet CREF:Cancérologie
Langue:Anglais